Dapagliflozin

Drugs used in diabetes | Endocrine System

Items (National)
8.9M
NHS Cost
£322.1M
Practices
7,140
Avg per Practice
1,252

Overview

Dapagliflozin is prescribed by 7,140 GP practices across England. In the last 12 months, 8,940,904 items were prescribed at a total cost of £322,069,401 to the NHS. It is classified under BNF Chapter Endocrine System, Section Drugs used in diabetes.

Monthly Prescribing Trend

Jun 2026
663,784
Jun 2026
638,577
Jun 2026
714,141
Jun 2026
707,894
Jun 2026
704,775
Jun 2026
763,299
Jun 2026
747,568
Jun 2026
785,958
Jun 2026
814,330
Jun 2026
747,293
Jun 2026
811,430
Jun 2026
834,711

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
B 265.3K 267 994 -20.7% ▼
NE 251.5K 146 1,722 +37.5% ▲
PE 248.3K 94 2,641 +110.9% ▲
E 246.7K 142 1,737 +38.7% ▲
M 186.3K 178 1,047 -16.4% ▼
LE 182.1K 128 1,423 +13.6% ▲
N 166.6K 124 1,344 +7.3% ▲
SW 165.9K 120 1,383 +10.4% ▲
L 157.4K 149 1,056 -15.6% ▼
NG 151.7K 140 1,084 -13.4% ▼
PO 150.3K 65 2,312 +84.6% ▲
CV 148.3K 110 1,348 +7.7% ▲
BS 141.0K 83 1,699 +35.7% ▲
ST 138.8K 87 1,595 +27.4% ▲
DN 135.4K 96 1,411 +12.7% ▲
S 134.7K 172 783 -37.5% ▼
SE 129.6K 121 1,071 -14.4% ▼
LS 129.3K 92 1,406 +12.2% ▲
NN 129.2K 67 1,929 +54.0% ▲
IP 121.3K 64 1,896 +51.4% ▲

BNF Classification

Related drugs in this section

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.